Decline depth
-22.2%
From rolling 252-day high of $30.42, 106d ago.
Past the 20% Watch threshold.
Red ListRecovering
NVSTEnvista Holdings Corporation
Healthcare · Medical Instruments & Supplies · mid-cap ($3.9B)
-22.2%
from rolling 252-day high of $30.42 set 2026-02-11 · 106d ago
Current
$23.67
Decline depth
-22.2%
Decline σ
8.0σ
TFC
1/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$NVST landed on the list 2026-03-30, down 20.2% from its 52-week high that day — now down -22.2%.
It has clawed back 8.8 percentage points off that level. It bottomed 26.4% below that high along the way.
Decline from the 52-week high as it stood on 2026-03-30 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
NVST qualifies for the Red List on decline depth.
Time-frame continuity
1/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
8.0σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (2.77% per day).
Past the ≥8σ Red List threshold — an extreme move.
The structural read
What price action says about NVST.
NVST qualifies for the Red List on decline depth — down -22.2% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause that often precedes further breakdown.
Cross-confirmation: decline sigma also reads 8.0σ over 20 bars.
Alongside that decline, our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames — moderate or strong time-frame-continuity (TFC) alignment — so the ticker also carries a Recovering badge. The two readings coexist: the tier tells you how deep the damage is, the Recovering badge tells you whether momentum may be turning. Recovering is not a buy signal; it's a structural read.
Broken Stocks stops here — it flags the structure, it doesn't build the upside case. Working out whether NVST's turn is investable is what our sister tool does: ConvictionEdge — triple-engine conviction research on names showing a recovery signal.
Upstream TFC read: moderate alignment, current phase daily. Last bar types — daily 3 (green), weekly 1 (green), monthly 3 (red).
Earnings on file: 2026-05-06. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $16.41
51.8% of range
52W high $30.42
Sector context · Healthcare
194 other Healthcare tickers are on Broken Stocks.
88
Red List
47
Amber
59
Watch
-36.0%
Median decline
Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →
Related — same sector
Closest decliners to NVST
WatchRecovering
HQY
HealthEquity, Inc.
Amber List
ENSG
The Ensign Group, Inc.
Watch
SNDX
Syndax Pharmaceuticals, Inc.
Amber List
ENTA
Enanta Pharmaceuticals, Inc.
Watch
SUPN
Supernus Pharmaceuticals, Inc.
Watch
TBPH
Theravance Biopharma, Inc.
Questions about NVST
What people ask.
Why is NVST on Broken Stocks?
NVST qualifies for the Red List on decline depth. It is down -22.2% from its rolling 252-day high of $30.42, set on 2026-02-11 — 106d ago. It additionally carries a Recovering badge — see below.
What does the Recovering badge mean for NVST?
Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — NVST is still Red List because the rolling-252-day decline hasn't healed, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier tells you how deep the damage is; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.
Is NVST a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. NVST is down -22.2% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is NVST a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is NVST trading inside its 52-week range?
At $23.67, NVST sits 51.8% of the way from its 52-week low ($16.41) to its 52-week high ($30.42). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has NVST been declining?
The current 22.2% decline accrued over 106d, which annualizes to roughly -76.4% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does NVST compare to its sector?
There are 194 other Healthcare tickers on Broken Stocks: 88 Red, 47 Amber, 59 Watch, with 107 showing recovering structural signals. Median sector decline is -36.0% — NVST's decline is shallower than the sector median.
Does NVST's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-06) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.